Close

ZS Pharma (ZSPH) Reports Publication of ZS-9 Phase 3 Data in NEJM

November 21, 2014 12:02 PM EST Send to a Friend
ZS Pharma (Nasdaq: ZSPH) announced the publication of previously unreleased detailed results from the ZS003 study in the New England ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login